Biomarker-based risk model to predict cardiovascular mortality in patients with stable coronary disease

Background: Currently, there is no generally accepted model to predict outcomes in stable coronary heart disease (CHD). Objectives: This study evaluated and compared the prognostic value of biomarkers and clinical variables to develop a biomarker-based prediction model in patients with stable CHD. M...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lindholm, Daniel (VerfasserIn) , Kleber, Marcus E. (VerfasserIn) , Grammer, Tanja B. (VerfasserIn) , März, Winfried (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 7 August 2017
In: Journal of the American College of Cardiology
Year: 2017, Jahrgang: 70, Heft: 7, Pages: 813-826
ISSN:1558-3597
DOI:10.1016/j.jacc.2017.06.030
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.jacc.2017.06.030
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0735109717378531
Volltext
Verfasserangaben:Daniel Lindholm, MD, PhD; Johan Lindbäck, MSc; Paul W. Armstrong, MD; Andrzej Budaj, MD, PhD; Christopher P. Cannon, MD; Christopher B. Granger, MD; Emil Hagström, MD, PhD; Claes Held, MD, PhD; Wolfgang Koenig, MD; Ollie Östlund, PhD; Ralph A.H. Stewart, MD; Joseph Soffer, MD; Harvey D. White, MB, ChB, DSc; Robbert J. de Winter, MD, PhD; Philippe Gabriel Steg, MD; Agneta Siegbahn, MD, PhD; Marcus E. Kleber, PhD; Alexander Dressel, Dr.rer.nat.; Tanja B. Grammer, MD; Winfried März, MD; Lars Wallentin, MD, PhD

MARC

LEADER 00000caa a2200000 c 4500
001 1577427440
003 DE-627
005 20250206095803.0
007 cr uuu---uuuuu
008 180709s2017 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jacc.2017.06.030  |2 doi 
035 |a (DE-627)1577427440 
035 |a (DE-576)507427440 
035 |a (DE-599)BSZ507427440 
035 |a (OCoLC)1341013607 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Lindholm, Daniel  |e VerfasserIn  |0 (DE-588)116247114X  |0 (DE-627)102617337X  |0 (DE-576)507426908  |4 aut 
245 1 0 |a Biomarker-based risk model to predict cardiovascular mortality in patients with stable coronary disease  |c Daniel Lindholm, MD, PhD; Johan Lindbäck, MSc; Paul W. Armstrong, MD; Andrzej Budaj, MD, PhD; Christopher P. Cannon, MD; Christopher B. Granger, MD; Emil Hagström, MD, PhD; Claes Held, MD, PhD; Wolfgang Koenig, MD; Ollie Östlund, PhD; Ralph A.H. Stewart, MD; Joseph Soffer, MD; Harvey D. White, MB, ChB, DSc; Robbert J. de Winter, MD, PhD; Philippe Gabriel Steg, MD; Agneta Siegbahn, MD, PhD; Marcus E. Kleber, PhD; Alexander Dressel, Dr.rer.nat.; Tanja B. Grammer, MD; Winfried März, MD; Lars Wallentin, MD, PhD 
264 1 |c 7 August 2017 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 7 August 2017 
500 |a Gesehen am 09.07.2018 
520 |a Background: Currently, there is no generally accepted model to predict outcomes in stable coronary heart disease (CHD). Objectives: This study evaluated and compared the prognostic value of biomarkers and clinical variables to develop a biomarker-based prediction model in patients with stable CHD. Methods: In a prospective, randomized trial cohort of 13,164 patients with stable CHD, we analyzed several candidate biomarkers and clinical variables and used multivariable Cox regression to develop a clinical prediction model based on the most important markers. The primary outcome was cardiovascular (CV) death, but model performance was also explored for other key outcomes. It was internally bootstrap validated, and externally validated in 1,547 patients in another study. Results: During a median follow-up of 3.7 years, there were 591 cases of CV death. The 3 most important biomarkers were N-terminal pro-B-type natriuretic peptide (NT-proBNP), high-sensitivity cardiac troponin T (hs-cTnT), and low-density lipoprotein cholesterol, where NT-proBNP and hs-cTnT had greater prognostic value than any other biomarker or clinical variable. The final prediction model included age (A), biomarkers (B) (NT-proBNP, hs-cTnT, and low-density lipoprotein cholesterol), and clinical variables (C) (smoking, diabetes mellitus, and peripheral arterial disease). This “ABC-CHD” model had high discriminatory ability for CV death (c-index 0.81 in derivation cohort, 0.78 in validation cohort), with adequate calibration in both cohorts. Conclusions: This model provided a robust tool for the prediction of CV death in patients with stable CHD. As it is based on a small number of readily available biomarkers and clinical factors, it can be widely employed to complement clinical assessment and guide management based on CV risk. 
650 4 |a cardiac troponin 
650 4 |a low-density lipoprotein cholesterol 
650 4 |a N-terminal pro-B-type natriuretic peptide 
650 4 |a risk prediction 
700 1 |a Kleber, Marcus E.  |d 1974-  |e VerfasserIn  |0 (DE-588)1030135177  |0 (DE-627)734830440  |0 (DE-576)377941379  |4 aut 
700 1 |a Grammer, Tanja B.  |d 1972-  |e VerfasserIn  |0 (DE-588)1030134952  |0 (DE-627)734830041  |0 (DE-576)377941018  |4 aut 
700 1 |a März, Winfried  |d 1958-  |e VerfasserIn  |0 (DE-588)1027603599  |0 (DE-627)729463605  |0 (DE-576)373454635  |4 aut 
773 0 8 |i Enthalten in  |a American College of Cardiology  |t Journal of the American College of Cardiology  |d New York, NY : Elsevier, 1983  |g 70(2017), 7, Seite 813-826  |h Online-Ressource  |w (DE-627)266884717  |w (DE-600)1468327-1  |w (DE-576)099603837  |x 1558-3597  |7 nnas 
773 1 8 |g volume:70  |g year:2017  |g number:7  |g pages:813-826  |g extent:14  |a Biomarker-based risk model to predict cardiovascular mortality in patients with stable coronary disease 
856 4 0 |u http://dx.doi.org/10.1016/j.jacc.2017.06.030  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0735109717378531  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180709 
993 |a Article 
994 |a 2017 
998 |g 1027603599  |a März, Winfried  |m 1027603599:März, Winfried  |d 60000  |d 61400  |e 60000PM1027603599  |e 61400PM1027603599  |k 0/60000/  |k 1/60000/61400/  |p 20 
998 |g 1030134952  |a Grammer, Tanja B.  |m 1030134952:Grammer, Tanja B.  |d 60000  |d 65300  |e 60000PG1030134952  |e 65300PG1030134952  |k 0/60000/  |k 1/60000/65300/  |p 19 
998 |g 1030135177  |a Kleber, Marcus E.  |m 1030135177:Kleber, Marcus E.  |d 60000  |d 61400  |e 60000PK1030135177  |e 61400PK1030135177  |k 0/60000/  |k 1/60000/61400/  |p 17 
999 |a KXP-PPN1577427440  |e 3016696266 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"7 August 2017"}],"note":["Available online 7 August 2017","Gesehen am 09.07.2018"],"recId":"1577427440","name":{"displayForm":["Daniel Lindholm, MD, PhD; Johan Lindbäck, MSc; Paul W. Armstrong, MD; Andrzej Budaj, MD, PhD; Christopher P. Cannon, MD; Christopher B. Granger, MD; Emil Hagström, MD, PhD; Claes Held, MD, PhD; Wolfgang Koenig, MD; Ollie Östlund, PhD; Ralph A.H. Stewart, MD; Joseph Soffer, MD; Harvey D. White, MB, ChB, DSc; Robbert J. de Winter, MD, PhD; Philippe Gabriel Steg, MD; Agneta Siegbahn, MD, PhD; Marcus E. Kleber, PhD; Alexander Dressel, Dr.rer.nat.; Tanja B. Grammer, MD; Winfried März, MD; Lars Wallentin, MD, PhD"]},"title":[{"title_sort":"Biomarker-based risk model to predict cardiovascular mortality in patients with stable coronary disease","title":"Biomarker-based risk model to predict cardiovascular mortality in patients with stable coronary disease"}],"relHost":[{"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"JACC","title":"Journal of the American College of Cardiology","title_sort":"Journal of the American College of Cardiology"}],"note":["Gesehen am 13.11.25","Ungezählte Beil.: Supplement"],"disp":"American College of CardiologyJournal of the American College of Cardiology","corporate":[{"role":"aut","display":"American College of Cardiology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"zdb":["1468327-1"],"issn":["1558-3597"],"eki":["266884717"]},"pubHistory":["1.1983 -"],"part":{"volume":"70","year":"2017","extent":"14","issue":"7","pages":"813-826","text":"70(2017), 7, Seite 813-826"},"titleAlt":[{"title":"JACC"}],"recId":"266884717","origin":[{"publisher":"Elsevier ; American College of Cardiology","dateIssuedDisp":"1983-","dateIssuedKey":"1983","publisherPlace":"New York, NY ; New York, NY"}]}],"physDesc":[{"extent":"14 S."}],"id":{"doi":["10.1016/j.jacc.2017.06.030"],"eki":["1577427440"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"display":"Lindholm, Daniel","role":"aut","family":"Lindholm","given":"Daniel"},{"display":"Kleber, Marcus E.","role":"aut","family":"Kleber","given":"Marcus E."},{"display":"Grammer, Tanja B.","role":"aut","family":"Grammer","given":"Tanja B."},{"role":"aut","display":"März, Winfried","given":"Winfried","family":"März"}],"language":["eng"]} 
SRT |a LINDHOLMDABIOMARKERB7201